📰 Interim Phase News
Page 3 - Interim Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Phase. Real-time updates on events, politics, business and more.
November 3, 2021
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from...
August 22, 2021
La vacuna de ADN fue aprobada para su uso de emergencia contra Covid-19 en la India; podrá administrarse a mayores de 12 años.
May 12, 2021
Clene Reports First Quarter 2021 Operating and Financial Highlights May 11, 2021 07:00 ET | Source: Clene Inc. Clene Inc. Salt Lake City, UNITED STATES Interim Phase 2 data indicate that CNM-Au8 has a homeostatic effect on brain bioenergetics and support its potential to drive meaningful neurological functional improvements in MS patients Awarded Michael J. Fox Foundation (MJFF) grant to accelerate development of CNM-Au8 as a treatment for Parkinson�...
March 3, 2021
Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy Bharat Biotech has announced Phase 3 clinical trial results of Covaxin, saying the vaccine demonstrates interim clinical efficacy of 81 per cent. advertisement Bharat Biotech said Phase 3 clinical trials for Covaxin involved 25,800 volunteers. Bharat Biotech said the Phase 3 clinical trials for Covaxin inv...